Development of glucose-responsive 'smart' insulin systems.


PURPOSE OF REVIEW The complexity of modern insulin-based therapy for type I and type II diabetes mellitus and the risks associated with excursions in blood-glucose concentration (hyperglycemia and hypoglycemia) have motivated the development of 'smart insulin' technologies (glucose-responsive insulin, GRI). Such analogs or delivery systems are entities that… (More)
DOI: 10.1097/MED.0000000000000345


6 Figures and Tables

Cite this paper

@article{Rege2017DevelopmentOG, title={Development of glucose-responsive 'smart' insulin systems.}, author={Nischay K Rege and Nelson F. B. Phillips and Michael Wei\ss}, journal={Current opinion in endocrinology, diabetes, and obesity}, year={2017}, volume={24 4}, pages={267-278} }